27766173|t|Multidrug Resistance of Acinetobacter Baumannii in Ladoke Akintola University Teaching Hospital, Osogbo, Nigeria
27766173|a|Acinetobacter baumannii is a ubiquitous pathogen that has emerged as a major cause of healthcare-associated infections at Ladoke Akintola University Teaching Hospital. Isolates were assayed according to standard protocol. The isolates were subjected to molecular techniques to detect blaOXA, blaTEM, blaCTX-M, and blaSHV genes in strains of the A. baumannii isolates. The prevalence of A. baumannii was 8.5% and was most prevalent among patients in the age group 51-60 (36%); the male patients (63.6%) were more infected than their female counterparts. Patients (72.7%) in the intensive care unit (ICU) were most infected with this organism. The isolates showed 100% resistance to both amikacin and ciprofloxacin and 90.9% to both ceftriaxone and ceftazidime, while resistance to the other antibiotics used in this study were: piperacillin (81.8%), imipenem (72.7%), gentamycin (72.2%), and meropenem (63.6%). None of the isolates was, however, resistant to colistin. PCR results showed that blaOXA, blaTEM, and blaCTX-M genes were positive in some isolates, while blaSHV was not detected in any of the isolates. This study has revealed that the strains of A. baumannii isolated are multiple drug resistant. Regular monitoring, judicious prescription, and early detection of resistance to these antibiotics are, therefore, necessary to check further dissemination of the organism.
27766173	24	47	Acinetobacter Baumannii	T007	UMLS:C0314787
27766173	51	95	Ladoke Akintola University Teaching Hospital	T092	UMLS:C0019994
27766173	97	112	Osogbo, Nigeria	T082	UMLS:C0028075
27766173	113	136	Acinetobacter baumannii	T007	UMLS:C0314787
27766173	199	231	healthcare-associated infections	T038	UMLS:C0010356
27766173	235	279	Ladoke Akintola University Teaching Hospital	T092	UMLS:C0019994
27766173	281	289	Isolates	T103	UMLS:C3494793
27766173	295	302	assayed	T058	UMLS:C1510438
27766173	316	333	standard protocol	T170	UMLS:C0442711
27766173	339	347	isolates	T103	UMLS:C3494793
27766173	366	386	molecular techniques	T062	UMLS:C1513384
27766173	397	439	blaOXA, blaTEM, blaCTX-M, and blaSHV genes	T017	UMLS:C1442492
27766173	443	450	strains	T007	UMLS:C0314787
27766173	458	470	A. baumannii	T007	UMLS:C0314787
27766173	471	479	isolates	T103	UMLS:C3494793
27766173	499	511	A. baumannii	T007	UMLS:C0314787
27766173	625	633	infected	T033	UMLS:C0439663
27766173	690	709	intensive care unit	T092	UMLS:C0021708
27766173	711	714	ICU	T092	UMLS:C0021708
27766173	726	734	infected	T033	UMLS:C0439663
27766173	759	767	isolates	T103	UMLS:C3494793
27766173	799	807	amikacin	T103	UMLS:C0002499
27766173	812	825	ciprofloxacin	T103	UMLS:C0008809
27766173	844	855	ceftriaxone	T103	UMLS:C0007561
27766173	860	871	ceftazidime	T103	UMLS:C0007559
27766173	903	914	antibiotics	T103	UMLS:C0003232
27766173	928	933	study	T062	UMLS:C2603343
27766173	940	952	piperacillin	T103	UMLS:C0031955
27766173	962	970	imipenem	T103	UMLS:C0066005
27766173	980	990	gentamycin	T103	UMLS:C3854019
27766173	1004	1013	meropenem	T103	UMLS:C0066005
27766173	1035	1043	isolates	T103	UMLS:C3494793
27766173	1071	1079	colistin	T103	UMLS:C0002499
27766173	1081	1084	PCR	T062	UMLS:C0032520
27766173	1085	1092	results	T033	UMLS:C0456984
27766173	1105	1139	blaOXA, blaTEM, and blaCTX-M genes	T017	UMLS:C1442492
27766173	1145	1153	positive	T033	UMLS:C1446409
27766173	1162	1170	isolates	T103	UMLS:C3494793
27766173	1178	1184	blaSHV	T017	UMLS:C1442492
27766173	1189	1201	not detected	T033	UMLS:C0442737
27766173	1216	1224	isolates	T103	UMLS:C3494793
27766173	1231	1236	study	T062	UMLS:C2603343
27766173	1259	1266	strains	T007	UMLS:C0314787
27766173	1270	1282	A. baumannii	T007	UMLS:C0314787
27766173	1329	1339	monitoring	T058	UMLS:C1283169
27766173	1351	1363	prescription	T058	UMLS:C0033080
27766173	1375	1384	detection	T058	UMLS:C1511790
27766173	1408	1419	antibiotics	T103	UMLS:C0003232